UNITED LAB: 2023 ANNUAL RESULTS ANNOUNCEMENT
UNITED LAB: POSITIVE PROFIT ALERT
UNITED LAB: DATE OF BOARD MEETING
UNITED LAB: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 29 February 2024
UNITED LAB: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 2024
UNITED LAB: UPDATED INFORMATION ON THE GROUP''S PRODUCT - IMIPENEM AND CILASTATIN SODIUM FOR INJECTION
UNITED LAB: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2023
UNITED LAB: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 November 2023
UNITED LAB: GRANT OF AWARD SHARES UNDER THE SHARE AWARD SCHEME
UNITED LAB: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2023
UNITED LAB: AMENDED AND RESTATED ARTICLES OF ASSOCIATION
UNITED LAB: POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 26 OCTOBER 2023
UNITED LAB: NOTICE OF ADJOURNED EXTRAORDINARY GENERAL MEETING
UNITED LAB: TYPHOON ARRANGEMENT FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON 9 OCTOBER 2023
UNITED LAB: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2023
UNITED LAB: Notification Letter to Non-register Holder and Request Form
UNITED LAB: Notification Letter to Shareholder and Change Request Form
UNITED LAB: 2023 INTERIM REPORT
UNITED LAB: Interim dividend for six months ended 30 June 2023
UNITED LAB: FDA APPROVAL OF IND FOR UBT251 INJECTION
No Data